Bank of Nova Scotia’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
QF
FCM
Bank of Nova Scotia's ROIV Position: Q2 2026 in Review
Bank of Nova Scotia reduced its Roivant Sciences (ROIV) stake by 5.5% in Q2 2026, selling an estimated $2.11M and leaving 1,238,830 shares worth $43.8M. The position accounts for 0.07% of the portfolio, ranked #221.
Bank of Nova Scotia first reported a position in ROIV in Q3 2023 and has held it in 4 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.
- Bank of Nova Scotia held 1,238,830 shares of Roivant Sciences worth $43.8M as of Q2 2026.
- Bank of Nova Scotia sold 71,557 Roivant Sciences shares in Q2 2026, an estimated $2.11M.
- Roivant Sciences made up 0.07% of Bank of Nova Scotia's portfolio in Q2 2026, its #221 holding.
- Bank of Nova Scotia first reported a position in Roivant Sciences in Q3 2023 and has held it in 4 quarters since.
- 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.
Based on Bank of Nova Scotia's 13F filing for Q2 2026, filed 12 Aug 2026.